Topics
Glioblastoma | Treatment | Clinical trials | Antisecretory factor
Home > Publications > Topics > Glioblastoma > Treatment > Clinical trials > Antisecretory factor
Ehinger
E, Darabi A, Visse E, Edvardsson C, Tomasevic G, Cederberg D,
Kinhult S, Rydelius A, Nilsson C, Belting M, Bengzon J, Siesjö
P.
Antisecretory factor as add-on
treatment for newly diagnosed glioblastoma, IDH wildtype: study
protocol for a randomized double-blind placebo-controlled trial.
Trials.
2025 Mar 13;26(1):86. doi:
10.1186/s13063-025-08792-z. PMID:
40083039. Interventional study protocol.
ˍ